Stockreport

BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin

BiomX Inc. COmmon Stock  (PHGE) 
PDF - Primary endpoints are safety and tolerability - Exploratory endpoints include proof of principle by measurement of C. acnes skin levels- Clinical data are expected at [Read more]